Baudax Bio Inc
(NASDAQ:BXRX)
$3.15
0.20[6.78%]
Last update: 3:09PM (Delayed 15-Minutes)
Get Real Time Here
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Baudax Bio Stock (NASDAQ:BXRX), Quotes and News Summary

Baudax Bio Stock (NASDAQ: BXRX) stock price, news, charts, stock research, profile.

Loading...
Day Range2.876 - 3.18052 Wk Range1.550 - 234.000Open / Close2.990 / -Float / Outstanding553.281K / 554.881K
Vol / Avg.360.974K / 2.081MMkt Cap1.748MP/E0.01150d Avg. Price3.620
Div / Yield (Forward)- / -%Payout Ratio-Total Float553.281KEPS6.700
Vandana Singh - Jan 24, 2023, 11:37AM
Globe Newswire - Nov 30, 2022, 4:50PM
Globe Newswire - Apr 13, 2022, 8:00AM
InvestorsObserver - Jan 25, 2023, 5:50AM
TalkMarkets - Jan 24, 2023, 12:07PM
InvestorPlace - Jan 24, 2023, 10:58AM
InvestorsObserver - Jan 6, 2023, 6:13AM
InvestorsObserver - Jan 5, 2023, 6:02AM
InvestorsObserver - Jan 3, 2023, 7:21AM
InvestorsObserver - Dec 30, 2022, 11:39AM
InvestorsObserver - Dec 29, 2022, 7:16AM
InvestorsObserver - Dec 27, 2022, 10:35AM
InvestorPlace - Dec 24, 2022, 4:27PM
InvestorsObserver - Dec 12, 2022, 5:57AM
InvestorPlace - Dec 9, 2022, 9:48AM
Sector: Health Care.Industry: Pharmaceuticals
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs, and a related proprietary chemical reversal agent and Dex-IN.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-15
REV
Q3 2022Est.ActualSurprise
EPS-21.200-15.600 5.6000
REV960.000M238.000K-959.762M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Baudax Bio (BXRX) stock?

A

You can purchase shares of Baudax Bio (NASDAQ: BXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Baudax Bio's (BXRX) competitors?

Q

What is the target price for Baudax Bio (BXRX) stock?

A

The latest price target for Baudax Bio (NASDAQ: BXRX) was reported by Noble Capital Markets on Tuesday, January 3, 2023. The analyst firm set a price target for 0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Baudax Bio (BXRX)?

A

The stock price for Baudax Bio (NASDAQ: BXRX) is $3.15 last updated Today at February 1, 2023 at 8:09 PM UTC.

Q

Does Baudax Bio (BXRX) pay a dividend?

A

There are no upcoming dividends for Baudax Bio.

Q

When is Baudax Bio (NASDAQ:BXRX) reporting earnings?

A

Baudax Bio’s Q4 earnings are confirmed for Wednesday, March 15, 2023.

Q

Is Baudax Bio (BXRX) going to split?

A

There is no upcoming split for Baudax Bio.

Q

What sector and industry does Baudax Bio (BXRX) operate in?

A

Baudax Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.